Engineered macroporous gelatin scaffolds enhance lymph node fibroblastic reticular cell identity and enable diabetogenic T cell immunomodulation

Teles, L. N., Beatty, L. A., Hernandez, A. V., Mendoza, M. A., Wilkes, Z. M., Dominick, V. P., Argy Telias, M. T., Miller, B., Huang, C.-Y., Bechi Genzano, C., Andreopoulos, F. M., Dauer, E. A., Creusot, R. J., & Tomei, A. A. (2026). Engineered macroporous gelatin scaffolds enhance lymph node fibroblastic reticular cell identity and enable diabetogenic T cell immunomodulation. Biomaterials, 324, 123460. https://doi.org/10.1016/j.biomaterials.2025.123460
Authors:
Leonor N Teles
Logan A Beatty
Ana V Hernandez
Marvin A Mendoza
Zachary M Wilkes
Vivien P Dominick
Michelle T Argy Telias
Benjamin Miller
Chun-Yuh Huang
Camillo Bechi Genzano
Fotios M Andreopoulos
Edward A Dauer
Remi J Creusot
Alice A Tomei
Affiliated Authors:
Camillo Bechi Genzano
Remi J Creusot
Author Keywords:
3d culture
antigen-specific therapies
immune engineering
lymphoid organs
stromal cells
tolerance
type 1 diabetes
Publication Type:
Article
Unique ID:
10.1016/j.biomaterials.2025.123460
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: